Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2011 Operating Results
Date:11/7/2011

BEDFORD, Mass., Nov. 7, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the fourth fiscal quarter and fiscal year ended September 24, 2011.

Highlights of the quarter include:

  • Revenues of $467.0 million resulting from year-over-year growth in all four operating segments.
  • Net income was $27.6 million, or $0.10 per diluted share, calculated in accordance with U.S. generally accepted accounting principles (GAAP).
  • Non-GAAP adjusted net income was $89.6 million, or $0.34 per diluted share, and adjusted EBITDA (non-GAAP adjusted earnings before interest, taxes, depreciation and amortization) was $160.3 million. A reconciliation of GAAP to non-GAAP results is included as an attachment to this press release.
  • Acquisition of Beijing Healthcome Technology Company, Ltd. on July 19, 2011, a manufacturer of mammography systems in China.
  • Three new products received 510(k) clearance by the Food and Drug Administration (FDA) and a fourth received CE Marking.

  • Fourth quarter fiscal 2011 revenues totaled $467.0 million, an increase of 9.0% compared to revenues of $428.3 million in the fourth quarter of fiscal 2010. This increase resulted from growth in revenues in all four of our operating segments, primarily from: (i) growth in Breast Health revenues of $21.5 million, or 10.9%, driven by a $12.4 million, or 9.2%, increase in product revenue and a $9.1 million, or 14.4%, increase in service revenue; (ii) an increase in Diagnostics revenues of $15.7 million, or 11.7%, primarily due to growth in ThinPrep revenues from our acquisition of TCT International Co. Ltd. (TCT) in Beijing, China on June 1, 2011, an in
    '/>"/>

    SOURCE Hologic, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

    Related medicine technology :

    1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
    2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
    3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
    4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
    5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
    6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
    7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
    8. Hologic Expands Healthcare Investment in Asia
    9. Hologic to Host Investor Reception at RSNA 2009
    10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
    11. Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
    (Date:5/4/2015)... May 4, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXI ... terms of the agreement, Isis is eligible to receive ... immediate $100 million up-front payment and a $55 million ... 2 study in patients with compromised kidney function. Isis ...
    (Date:5/4/2015)... DIEGO , May 4, 2015 ... oncology company focused on the clinical development of ... data showing mitochondria-specific effects of the Company,s investigational ... enhanced anti-tumor activity when combined with a tyrosine-kinase ... found ME-344 to be a potent inhibitor of ...
    Breaking Medicine Technology:HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5
    ... Inc. (NYSE Amex: ANX ) today announced that ... at the 10th Annual BIOInvestor Forum Conference on Wednesday, October ... Cliff Salon at the Palace Hotel in San Francisco. ... and slide presentation on the ADVENTRX Pharmaceuticals web site at ...
    ... Innocoll, Inc. announced it has entered into a ... for CollaGUARD surgical adhesion barrier for the prevention of ... Dr. Michael Myers, President and CEO stated "This ... an increasingly important and dynamic market for medical products ...
    Cached Medicine Technology:Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 2Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD 3
    (Date:5/4/2015)... (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive Director ... a 2015-2016 inductee into its VIP Woman of ... prestigious distinction for leadership in business. NAPW is ... women, boasting more than 700,000 members and over ...
    (Date:5/4/2015)... Garden City, NY (PRWEB) May 05, 2015 ... honors Gloria M. Betancourt as a ... Year Circle. She is recognized with this prestigious distinction ... networking organization exclusively for professional women, boasting more than ... "I'm pleased to present Gloria with this important honor," ...
    (Date:5/4/2015)... London, UK (PRWEB) May 04, 2015 ... to witness a 7.7% CAGR. Currently, the European and ... the world, while the North American probiotic market lags ... of local population. , The North American probiotic ... of over 58%), followed by Canada and Mexico. The ...
    (Date:5/4/2015)... Monkton, MD (PRWEB) May 04, 2015 ... affecting families for generations. While it can have ... in disabling and catastrophic events. Hereditary Hemorrhagic Telangiectasia ... of blood vessels that lack normal capillary connections between ... nose can cause frequent, severe nosebleeds, but may also ...
    (Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
    Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Gloria Betancourt, Receptionist at Consulate Health Care, into its 2015-2016 VIP Woman of the Year Circle 2Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Milton Hershey School Names 2015 Alumnus of the Year 2
    ... Free from LTC Financial Partners, KIRKLAND, Wash., ... care,for an incapacitated parent or spouse, the impact ... estate or inheritance. And your loved,one,s daily needs ... *(PHOTO 72dpi: Send2Press.com/mediaboom/08-0227-JonasRoeser_72dpi.jpg), *(Photo Caption: LTC Senior ...
    ... Israel, Feb. 27 Shamir,Optical Industry Ltd. (Nasdaq: ... year end 2007 earnings results on Thursday, March 6, ... results at 9:00 A.M. EST,that morning., The conference ... To,listen live, please go to http://www.kcsa.com approximately ...
    ... 2008 -- A new study led by researchers at the ... diabetes who reported taking less insulin than prescribed had a ... complications than those who did not skip needed insulin shots. ... Care. , The study highlights the dangers of insulin restriction ...
    ... new article suggests that the United States government ... Cuba into a biomedical research institute dedicated to ... the open-access journal PLoS Neglected Tropical Diseases, Editor-in-Chief ... be in an optimal position to directly address ...
    ... Ventas, Inc. (NYSE:,VTR) ("Ventas" or the "Company") announced ... A. Cafaro, and Executive Vice,President and Chief Investment Officer, ... at the Citi 2008 Global Property CEO,Conference in Palm ... p.m.,Eastern Time., Those wishing to access the presentation ...
    ... Kansas City-based company connects, educates and entertains sports ... Sports enthusiasts have a new,online hotspot with Kansas ... have collaborated to produce AthletixNation.com, the premier,community for ... ultimate goal of AthletixNation.com is to have a ...
    Cached Medicine News:Health News:Long Term Care Newsletter Helps Preserve Solvency & Sanity While Caring for Loved One 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results 2Health News:Joslin study finds restricting insulin doses increases mortality risk 2Health News:Joslin study finds restricting insulin doses increases mortality risk 3Health News:From detainee facility to health advocacy center: A new role for Guantanamo? 2Health News:AthletixNation.com Launches Sports Website and Community Programs 2
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: